12.22.14
BASi
4Q Revenues: $6.4 million (+17%)
4Q Loss: $404,000 (earnings were $252,000 4Q13)
YTD Revenues: $24.6 million (+11%)
YTD Loss: $1.1 million (earnings were $773,000 YTD13)
Comments: Service revenue for the quarter was up 23% to $4.9 million, due to an increase in Preclinical services studies offset slightly by lower Bioanalytical services revenue. Product revenue was flat at $1.5 million. Impairment charges of $374,000 impacted results in the quarter and FY.
4Q Revenues: $6.4 million (+17%)
4Q Loss: $404,000 (earnings were $252,000 4Q13)
YTD Revenues: $24.6 million (+11%)
YTD Loss: $1.1 million (earnings were $773,000 YTD13)
Comments: Service revenue for the quarter was up 23% to $4.9 million, due to an increase in Preclinical services studies offset slightly by lower Bioanalytical services revenue. Product revenue was flat at $1.5 million. Impairment charges of $374,000 impacted results in the quarter and FY.